← Human Trials & Peer-Reviewed Studies

Effects of Zinc Supplementation on Metabolomic Profiles in Tanzanian Infants: A Randomized Trial.

Plain-language guide to PMID 38092153 (2024): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 50 infants.

Key Facts

PMID
38092153
Journal
The Journal of nutrition
Year
2024
Study type
Randomized Controlled Trial
Authors
Liu E et al. (8 authors)
DOI
10.1016/j.tjnut.2023.12.011
Registered trial
NCT00421668

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

This study aimed to examine the effect of zinc supplementation on metabolic profiles in Tanzanian infants aged 6 wk and 6 mo.

Two-way repeated measures analysis of variance with compound symmetry covariance structures were used to compare metabolome levels over time between infants in the 2 treatment arms.

Why It Was Studied

However, the metabolic pathways underlying these outcomes are unclear, and metabolomic data from humans undergoing zinc supplementation, particularly infants, are generally lacking.

Who Took Part

The abstract describes 50 infants taking part.

By PubMed's age tags, the people studied were infants, young children and children.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

Some infants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

Principal component analysis (PCA) was used to summarize metabolomic data from all samples.

What Was Measured

However, the metabolic pathways underlying these outcomes are unclear, and metabolomic data from humans undergoing zinc supplementation, particularly infants, are generally lacking.

PubMed files the paper under topics including Zinc, Tanzania, Dietary Supplements and Morbidity.

The authors tagged it with the keywords infants, metabolomic analysis, randomized controlled trial and zinc supplementation.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 50 infants.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (The Journal of nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.